NPPB and Stroke: Mean serum concentrations of sST2 and NT-proBNP in patients that later experienced cardiovascular death or CHF were higher than those of patients that did not experience these outcomes [11], and similarly, these marker levels were higher in patients that experienced stroke than in those that did not [24].